# DCE CT/MRI Scanning Study in Patients With Solid Tumours (AstraZeneca and Royal Marsden Hospital Imaging Study)

> **NCT00748891** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 35 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Recentin (Cediranib)

## Key facts

- **NCT ID:** NCT00748891
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2010-02
- **Final completion:** 2010-11
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2011-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00748891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00748891, "DCE CT/MRI Scanning Study in Patients With Solid Tumours (AstraZeneca and Royal Marsden Hospital Imaging Study)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00748891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*